| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Product sales | 5,506,122 | 6,444,880 | 8,067,174 | 6,011,573 |
| Costs of goods sold | 3,143,024 | 3,626,956 | 4,713,202 | 4,428,019 |
| Gross margin | 2,363,098 | 2,817,924 | 3,353,972 | 1,583,554 |
| Sales and marketing expenses | 919,291 | 696,086 | 856,658 | 844,045 |
| Product development expenses | 694,311 | 831,858 | 756,847 | 786,136 |
| Administrative expenses | 729,421 | 720,418 | 622,843 | 528,267 |
| Operating expenses | 2,343,023 | 2,248,362 | 2,236,348 | 2,158,448 |
| Net operating income (loss) | 20,075 | 569,562 | 1,117,624 | -574,894 |
| Other (expenses) income, net | -155,367 | -65,778 | 331,263 | -125,456 |
| (loss) income before income taxes | -135,292 | 503,784 | 1,448,887 | -700,350 |
| Income tax expense | 4,456 | 1,904 | 1,904 | 1,340 |
| Net (loss) income | -139,748 | 501,880 | 1,446,983 | -701,690 |
| Basic (in dollars per share) | -0.02 | 0.06 | 0.16 | -0.09 |
| Diluted (in dollars per share) | -0.02 | 0.06 | 0.16 | -0.09 |
| Diluted weighted average common shares outstanding (in shares) | 9,045,851 | 9,031,282 | 8,980,602 | 8,164,423 |
| Weighted average common shares outstanding - basic (in shares) | 9,045,851 | 9,031,282 | 8,980,602 | 8,164,423 |
IMMUCELL CORP DE (ICCC)
IMMUCELL CORP DE (ICCC)